Clinical Trial Update: Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating transplantation of human spinal cord-derived neural stem cells (NSI-566) for amyotrophic lateral sclerosis, sponsored by Neuralstem I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• NSI-566 Neural Stem Cells (neural stem cells)

Snippet

Sponsor: Neuralstem Inc. | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: UNKNOWN